Physician profile
Christopher B Miller
NPI 1396742508
$1,563.33
in general payments reported to CMS, 2019-2025
20 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $244 · 2021: $214 · 2022: $21.88 · 2023: $79.18 · 2024: $149 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $791.61 | 2019-2024 | Veozah, Myrbetriq |
| Novo Nordisk INC | $163.43 | 2019-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $91.45 | 2021-2025 | |
| Amgen INC. | $80.77 | 2019-2025 | Otezla, Repatha |
| Lilly USA, LLC | $50.27 | 2019-2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $50.24 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.95 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $37.12 | 2025 | Voquezna |
| Dexcom, INC. | $36.53 | 2025 | Dexcom G6 Transmitter |
| Allergan, INC. | $35.98 | 2019 | |
| Exact Sciences Corporation | $28.87 | 2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $28.36 | 2019 | |
| Merck Sharp & Dohme LLC | $26.16 | 2025 | Pifeltro |
| Phadia US INC. | $15.72 | 2019 | |
| Shire North American Group INC | $15.47 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.70 | 2019 | |
| Mylan Specialty L.P. | $12.99 | 2019 | |
| Pfizer INC. | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.